Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insecticides.

Christopher P. Holstege1, Alexander B. Baer

  • 1Division of Medical Toxicology, University of Virginia, PO Box 800774, Charlottesville, VA 22908, USA. ch2xf@virginia.edu

Current Treatment Options in Neurology
|December 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Organophosphate (OP) insecticide poisoning is a significant health risk. Treatment involves atropine and pralidoxime, with careful consideration for specific syndromes like intermediate syndrome and delayed neuropathy.

Area of Science:

  • Toxicology
  • Clinical Medicine
  • Pharmacology

Background:

  • Organophosphate (OP) insecticide toxicity presents a major global health concern, leading to significant morbidity and mortality.
  • Clinical manifestations of OP poisoning are diverse, encompassing cholinergic syndromes, flaccid paralysis, and seizures.

Purpose of the Study:

  • To outline the primary therapeutic strategies for organophosphate poisoning.
  • To clarify the appropriate use of atropine and pralidoxime in managing OP toxicity.
  • To highlight potential long-term complications of OP exposure.

Main Methods:

  • Review of established clinical guidelines and therapeutic protocols for organophosphate poisoning.
  • Analysis of pharmacological actions of atropine and pralidoxime in OP toxicity.

Related Experiment Videos

  • Identification of key clinical syndromes and their management.

    • Main Results:

    • Atropine, pralidoxime, and benzodiazepines are the cornerstone treatments for OP poisoning.
    • Tachycardia is not a contraindication for atropine use; it aids in managing respiratory distress, bradycardia, and seizures.
    • Continuous pralidoxime infusion is recommended for acute toxicity, and specific syndromes like intermediate syndrome and OP-induced delayed neuropathy require attention.

    Conclusions:

    • Effective management of organophosphate poisoning relies on prompt and appropriate administration of atropine and pralidoxime.
    • Understanding the varied clinical presentations and potential delayed complications is crucial for patient outcomes.
    • Therapeutic decisions, such as atropine use in tachycardia and pralidoxime infusion, should be guided by the patient's specific condition.